Biolinq

About:

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.

Top Investors: EOFlow, Alpha Wave Global, Able Partners, RiverVest, Alpha Wave Ventures

Description:

Biolinq is a digital health platform developer that aims to create a pipeline of biomonitoring solutions. The company's platform includes a skin-applied, minimally invasive electrochemical biosensor that analyzes biomarkers in the interstitial fluid to provide actionable health information while continuously monitoring multiple biomarkers, allowing diabetic patients to monitor their blood glucose levels.

Total Funding Amount:

$254M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2012-01-01

Contact Email:

careers(AT)biolinq.me

Founders:

Jared Tangney, Joshua Windmiller, Stewart Roberts

Number of Employees:

51-100

Last Funding Date:

2024-04-04

IPO Status:

Private

Industries: